Biblio

Author Title [ Type

] Year

Filters: First Letter Of Title is W [Clear All Filters]

Journal Article

Krimpenfort P, Berns A. Wnt Down, Tumors Wind Up?. Cell. 2015;161(7):1494-1496.

Visweswaran M, Schiefer L, Arfuso F, Dilley RJ, Newsholme P, Dharmarajan A. Wnt Antagonist Secreted Frizzled-Related Protein 4 Upregulates Adipogenic Differentiation in Human Adipose Tissue-Derived Mesenchymal Stem Cells. PLoS One. 2015;10(2):e0118005.

Y Narayanaa K, P Kumar N, Warrier S, Perumalsamy LR, Dharmarajan A. Wnt Antagonist as therapeutic targets in Ovarian Cancer. Int J Biochem Cell Biol. 2022:106191.

Xin H-W, Ambe CM, Ray S, Kim B-K, Koizumi T, Wiegand GW, Hari D, Mullinax JE, Jaiswal KR, Garfield SH, et al. Wnt and the cancer niche: paracrine interactions with gastrointestinal cancer cells undergoing asymmetric cell division. J Cancer. 2013;4(6):447-57.

Buikema JW, Lee S, Goodyer WR, Maas RG, Chirikian O, Li G, Miao Y, Paige SL, Lee D, Wu H, et al. Wnt Activation and Reduced Cell-Cell Contact Synergistically Induce Massive Expansion of Functional Human iPSC-Derived Cardiomyocytes. Cell Stem Cell. 2020;27(1):50-63.e5.

Chi R-PAlicia, Xu X, Li J-L, Xu X, Hu G, Brown P, Willson C, Kirsanov O, Geyer C, Huang C-L, et al. WNK1 is required during male pachynema to sustain fertility. iScience. 2023;26(9):107616.

Ni C-X, Qi Y, Zhang J, Liu Y, Xu W-H, Xu J, Hu H-G, Wu Q-Y, Wang Y, Zhang J-P. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway. Oncotarget. 2016.

Heo SChul, Kwon YWoo, Jang IHo, Jeong GOk, Yoon JWon, Kim CDae, Kwon SMo, Bae Y-S, Kim JHo. WKYMVm-induced activation of formyl peptide receptor 2 stimulates ischemic neovasculogenesis by promoting homing of endothelial colony forming cells. Stem Cells. 2013.

Justice M, Carico ZM, Stefan HC, Dowen JM. A WIZ/Cohesin/CTCF Complex Anchors DNA Loops to Define Gene Expression and Cell Identity. Cell Rep. 2020;31(2):107503.

Viinikainen K, Isohanni P, Kanerva J, Lönnqvist T, Lauronen L. Without ENMG, detecting pediatric vincristine neuropathy is a challenge. Clin Neurophysiol Pract. 2024;9:94-101.

Pietsch C, Ennuschat N, Härtel S, Liebert UG. Within-host evolution of virus variants during chronic infection with novel GII.P26-GII.26 norovirus. J Clin Virol. 2018;108:96-102.

Kuang Z, Bai J, Ni L, Hang K, Xu J, Ying L, Xue D, Pan Z. Withanolide B promotes osteogenic differentiation of human bone marrow mesenchymal stem cells via ERK1/2 and Wnt/β-catenin signaling pathways. Int Immunopharmacol. 2020;88:106960.

Gupta SKumar, Gohil D, Dutta D, Panigrahi GCh, Gupta P, Dalvi K, Khanka T, Yadav S, Kaushal RKumar, Chichra A, et al. Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect. Int Immunopharmacol. 2023;121:110437.

Kakar SS, Ratajczak MZ, Powell KS, Moghadamfalahi M, Miller DM, Batra SK, Singh SK. Withaferin A Alone and in Combination with Cisplatin Suppresses Growth and Metastasis of Ovarian Cancer by Targeting Putative Cancer Stem Cells. PLoS One. 2014;9(9):e107596.

Xing Z, Su A, Mi L, Zhang YJ, He T, Qiu Y, Wei T, Li Z, Zhu J, Wu W. Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms. Drug Des Devel Ther. 2023;17:2909-2929.

Sun YEve, Cheng L, Hu K. With NuRD, HDACs Go "Nerdy". Dev Cell. 2014;30(1):9-10.

Beutel G, Liebregts T, Böll B. [With a tumor diagnosis in the intensive care unit]. Inn Med (Heidelb). 2023.

Martins AR, Matias GSS, Batista VF, Miglino MA, Fratini P. Wistar rat dermis recellularization. Res Vet Sci. 2020;131:222-231.

Knowles BB. The Wistar Legacy to Embryonic Stem Cell Research. Monoclon Antib Immunodiagn Immunother. 2014.

Zheng Y, Shen P, Tong M, Li H, Ren C, Wu F, Li HY, Yang H, Cai B, Du W, et al. WISP2 downregulation inhibits the osteogenic differentiation of BMSCs in congenital scoliosis by regulating Wnt/β-catenin pathway. Biochim Biophys Acta Mol Basis Dis. 2023:166783.

Pille M, Avila J, Sanchez GSanchez, Goetgeluk G, De Munter S, Jansen H, Billiet L, Weening K, Xue H, Bonte S, et al. The Wiskott-Aldrich syndrome protein is required for positive selection during T-cell lineage differentiation. Front Immunol. 2023;14:1188099.

Yuan B, Zhou X, Suzuki K, Ramos-Mandujano G, Wang M, Tehseen M, Cortés-Medina LV, Moresco JJ, Dunn S, Hernández-Benítez R, et al. Wiskott-Aldrich syndrome protein forms nuclear condensates and regulates alternative splicing. Nat Commun. 2022;13(1):3646.

Mansour R, El-Orfali Y, Saber A, Noun D, Youssef N, Youssef Y, Hanna-Wakim R, Dbaibo G, Abboud M, Massaad MJ. Wiskott-Aldrich syndrome in four male siblings from a consanguineous family from Lebanon. Clin Immunol. 2020:108573.

Buchbinder D, Nugent DJ, Fillipovich AH. Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments. Appl Clin Genet. 2014;7:55-66.

Vallée TC, Glasmacher JS, Buchner H, Arkwright PD, Behrends U, Bondarenko A, Browning MJ, Buchbinder DK, Cattoni A, Chernyshova L, et al. Wiskott-Aldrich Syndrome: A study on 577 patients defining the genotype as a predictive biomarker for disease severity. Blood. 2024.

Pages